Amneal Acquires India’s Puniska To Double Injectables Business

As Company Looks To Enter US Biosimilars Market In 2022

 
• By Akriti Seth
Business Graph
Amneal reports growth in its generics and specialty segment • Source: Alamy

More from Generics

More from Products